A New Starting Point for Patient Support: Technology-Driven Hub Services

Today’s guest post comes from Erica Conroy, VP of Specialty at CoverMyMeds and Bill Nolan, VP/GM of Access and Adherence at RxCrossroads by McKesson. Erica and Bill discuss the challenges that specialty pharmacy patients encounter when accessing and utilizing hub services. They also present evidence showing that how hub services positively affect patient outcomes. To learn more, download CoverMyMeds’ whitepaper: Revolutionizing Patient Access and Support for Specialty Therapies: Multiple Sclerosis. Read on for their insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed … Continue reading A New Starting Point for Patient Support: Technology-Driven Hub Services

Help for the Patient Journey–Electronic Modernization of Medication Access

Today’s guest post comes from Ben Stormer, VP of Product Development and Strategy for Specialty at CoverMyMeds. Ben discusses how automatic, streamlined electronic enrollment in patient hub services will improve patients’ adherence to specialty medication. To learn more, connect with CoverMyMeds at the Asembia Specialty Pharmacy Summit next week in Las Vegas. Read on for Ben’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Help for the Patient Journey–Electronic Modernization of Medication Access

TrialCard: The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism

Today’s guest post comes from Scott Dulitz, Chief Strategy Officer at TrialCard. Scott discusses the evolution of pharmaceutical manufacturer hub programs. As he explains, crucial industry trends are changing how patients and healthcare providers interact with and evaluate support services. To learn more about TrialCard’s patient management solution, view TrialCard’s recent video: Emerging Market Trends Shape Hub/Market Access Services, or email Scott at scott.dulitz@trialcard.com. Read on for Scott’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only. … Continue reading TrialCard: The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism

Drug Price Transparency and Rebate Reform Take Center Stage

Today’s guest post comes from Kay Morgan, Vice President of Drug Information Excellence at Elsevier. Kay discusses her thoughts on the latest developments on rebate reform and drug price transparency reform. Learn more by downloading Elsevier’s white paper: Prescription Drug Transparency Reform: While You Wait. Read on for Kay’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Drug Price Transparency and Rebate Reform Take Center Stage

Addressing the Rising Impact of Co-Pay Accumulators on Patients

Today’s guest post comes from Bill Nolan, VP/GM of Access and Adherence at RxCrossroads by McKesson. Bill discusses the proliferation of co-pay accumulators and the negative effects they can have on patients, particularly those with high-deductible health plans. He offers solutions that biopharma companies can embrace to mitigate the impact, including the adoption of patient-centric support. To learn more, download McKesson’s white paper: The Impact of Accumulators on Co-pay Programs. Read on for Bill’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is … Continue reading Addressing the Rising Impact of Co-Pay Accumulators on Patients

Recognising the impact of reading lists on diversifying curricula

This is a guest post from Sarah Field, Liaison Librarian at the University of Kent.   Preparing for our forthcoming presentation at Talis Insight Europe 2019 has given […] The post Recognising the impact of reading lists on diversifying curricula appeared first on e-Learning Feeds. Powered by WPeMatico Continue reading Recognising the impact of reading lists on diversifying curricula

Delivering an Enhanced Patient and Prescriber Experience for Personalized Therapies

Today’s guest post comes from Rob Brown, VP/GM of Pharmacy Solutions at McKesson Life Sciences. Rob provides insights on designing patient-centric channel strategies. He also reviews the role of centralized hub services with an integrated specialty pharmacy. Click here to download McKesson’s case study. It describes how an emerging biotech company streamlined access for patients with an acute complex condition. Read on for Rob’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Delivering an Enhanced Patient and Prescriber Experience for Personalized Therapies

Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Today’s guest post comes from Tim Ogren, Senior Vice President, Products at TrialCard. Tim discusses the rise in pharmacies making fraudulent claims and the costs of these claims. Learn more in Trialcard’s white paper: Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected? TrialCard developed Spotlight®, a pharmacy fraud detection product for manufacturers. To learn more, contact Tim Ogren, TrialCard’s Senior Vice President of Products, at tim.ogren@trialcard.com. Read on for Tim’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal … Continue reading Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

Today’s guest post comes from Derek Rago, VP/GM of Data, Evidence & Insights at McKesson Life Sciences. Derek discusses how biopharma companies can use real-world evidence to gain efficiencies and build effective strategies. He also outlines the key elements of an effective data and analytics strategy. To learn more about McKesson’s data, evidence and insights solutions, visit McKesson.com/DataInsights. Read on for Derek’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

Three Reasons to Join the Industry-Wide Effort to Speed Time-to-Therapy for Specialty Pharmacy

Today’s guest post comes from Lee Ann Stember, President and CEO of the National Council for Prescription Drug Programs (NCPDP). Lee Ann discusses the crucial importance of getting patients timely access to specialty therapies. She invites Drug Channels readers to participate in NCPDP’s specialty pharmacy work group and its four task groups. Your participation will help establish and refine standards that will benefit patients and all industry participants. It’s simple. Create an account at www.dms.ncpdp.org and then select your preferred task groups. You can also click here to register for upcoming NCPDP meetings. Read on for Lee Ann’s insights and to get more … Continue reading Three Reasons to Join the Industry-Wide Effort to Speed Time-to-Therapy for Specialty Pharmacy